Trisol's Transcatheter Tricuspid Valve Replacement (TTVR) system is designed to treat severe to torrential tricuspid regurgitation (TR), a condition in which the tricuspid valve fails to close ...

TRiCares SAS (“TRiCares”), a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, ...

Edwards Lifesciences has secured European approval for its transcatheter tricuspid valve replacement system, which the company described as the first minimally invasive therapy of its kind to receive ...

DUBLIN--(BUSINESS WIRE)--The "Tricuspid Valve Repair Market Size, Share & Trends Analysis Report By End-use (Ambulatory Surgical Centers, Hospitals), By Indication (Tricuspid Valve Regurgitation, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Transcatheter tricuspid valve replacement using the ...

NEW YORK CITY -- Recent device approvals officially put transcatheter tricuspid valve intervention (TTVI) on the map for symptomatic severe tricuspid regurgitation (TR), though workforce challenges ...

SAN FRANCISCO, CA—Patients with severe tricuspid regurgitation (TR) treated with transcatheter valve replacement experienced a significant improvement in TR grade and had “meaningful” improvements in ...

Edwards Lifesciences has claimed the FDA’s first approval of a transcatheter replacement implant for a leaky tricuspid heart valve, three months after garnering a green light in Europe. The Evoque, ...

According to the NIH, about 1.6 million people in the U.S. suffer from a condition where the tricuspid valve does not ...

Please provide your email address to receive an email when new articles are posted on . Transcatheter tricuspid valve replacement was feasible in most of a cohort of patients with severe tricuspid ...

Edwards Lifesciences has received US Food and Drug Administration (FDA) approval for its Evoque tricuspid valve replacement system, which becomes the first transcatheter therapy to be approved in the ...

DUBLIN--(BUSINESS WIRE)--CroíValve, a pioneering medical device company focused on the development of a novel transcatheter device for the treatment of severe+ tricuspid regurgitation (TR), announced ...